Compare Abeona Therapeutics Inc (ABEO) vs OneSpan Inc (OSPN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs OneSpan Inc — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while OneSpan Inc trades at $16.25 (market cap $600.69M). The key difference: OneSpan Inc is the larger of the two by market cap, and OneSpan Inc pays a 3.19% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | OSPN | |
|---|---|---|
Market Cap | $421.19M | $600.69M |
Sector | Health | Technology |
52-Week High | $7.45 | $16.78 |
52-Week Low | $4.17 | $10.15 |
Enterprise Value | $276.10M | $569.77M |
Dividend Yield | — | 3.19% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About OneSpan Inc
OneSpan Inc. is a global leader in providing digital agreement security solutions. The company's platform helps organizations, primarily in the financial services sector, to secure their digital agreements and transactions, including e-signatures, multi-factor authentication, and transaction monitoring. OneSpan's technology is focused on protecting customers from fraud and meeting regulatory compliance requirements in a digital-first environment.
Read more on OSPN →
